DUBLIN,
Nov. 29, 2016
/PRNewswire/ -- Allergan plc
(NYSE:AGN) a leading global pharmaceutical
company, today announced that Brent
Saunders, Allergan's Chairman, CEO and President,
will participate in a fireside chat at the 2016 Citi Global
Healthcare Conference on
Thursday, December
8th, 2016 at
11:00 a.m. ET in
New York, New
York.
Logo -
http://photos.prnewswire.com/prnh/20150612/222796LOGO
The presentation will be webcast live and can be accessed
on Allergan's Investor Relations web site at
http://ir.allergan.com. The
webcast can also be accessed through the following
http://www.veracast.com/webcasts/citigroup/healthcare2016/68205190244.cfm
An archived version of the webcast will be available
approximately two hours after the live presentation ends and can be
accessed at the same locations for 180 days.
About Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global
pharmaceutical company and a leader in a new industry model –
Growth Pharma. Allergan is focused on developing,
manufacturing and commercializing branded pharmaceuticals, devices
and biologic products for patients around the world.
Allergan markets a portfolio of leading brands and
best-in-class products for the central nervous system, eye care,
medical aesthetics and dermatology, gastroenterology, women's
health, urology and anti-infective therapeutic
categories.
Allergan is an industry leader in Open Science, the
Company's R&D model, which defines our approach to identifying
and developing game-changing ideas and innovation for better
patient care. This approach has led to Allergan building one
of the broadest development pipelines in the pharmaceutical
industry with 70+ mid-to-late stage pipeline programs in
development.
Our Company's success is powered by our more than 16,000
global colleagues' commitment to being Bold for Life.
Together, we build bridges, power ideas, act fast and drive results
for our customers and patients around the world by always doing
what is right.
With commercial operations in approximately 100 countries,
Allergan is committed to working with physicians, healthcare
providers and patients to deliver innovative and meaningful
treatments that help people around the world live longer, healthier
lives every day.
For more information, visit Allergan's website at
www.Allergan.com.
Forward-Looking Statement
Statements contained in this press release that refer to
future events or other non-historical facts are forward-looking
statements that reflect Allergan's current perspective of existing
trends and information as of the date of this release. Except as
expressly required by law, Allergan disclaims any intent or
obligation to update these forward-looking statements. Actual
results may differ materially from Allergan's current expectations
depending upon a number of factors affecting Allergan's business.
These factors include, among others, the difficulty of predicting
the timing or outcome of FDA approvals or actions, if any; the
impact of competitive products and pricing; market acceptance of
and continued demand for Allergan's products; difficulties or
delays in manufacturing; and other risks and uncertainties detailed
in Allergan's periodic public filings with the Securities and
Exchange Commission, including but not limited to Allergan's Annual
Report on Form 10-K for the year ended December 31, 2015 and Quarterly Report on Form
10-Q for the quarter ended September 30,
2016 (certain of such periodic public filings having been
filed under the "Actavis plc" name). Except as expressly required
by law, Allergan disclaims any intent or obligation to update these
forward-looking statements.
CONTACTS:
Allergan:
Investors:
Lisa
DeFrancesco
(862) 261-7152
Media:
Mark Marmur
(862) 261-7558
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/allergan-to-present-at-2016-citi-global-healthcare-conference-300369534.html
SOURCE Allergan plc